HR 7050
Homeopathic Drug Product Safety, Quality, and Transparency Act
Jurisdiction
US Congress
Session
119th Congress (2025-2026)
Last updated at
Jun 14, 2026, 2:37 AM
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
This bill, the Homeopathic Drug Product Safety, Quality, and Transparency Act, aims to regulate homeopathic drug products within the existing Federal Food, Drug, and Cosmetic Act. It clarifies definitions related to homeopathic drugs and establishes a specific pathway for their regulation, separate from broader drug safety standards. The bill seeks to ensure consumer access to safe homeopathic products while preventing the imposition of overly restrictive regulations. It also creates an advisory committee to guide the FDA’s approach to these products.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.